84 related articles for article (PubMed ID: 2527475)
21. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
22. Effect of a chronic infusion of atrial natriuretic peptide on vascular reactivity in normotensive and renal hypertensive rats.
Fenoy FJ; Salazar FJ; Hernandez I; Marin N; Quesada T
Proc Soc Exp Biol Med; 1990 Nov; 195(2):270-3. PubMed ID: 2146688
[TBL] [Abstract][Full Text] [Related]
23. Hormone and hemodynamic responses to atrial natriuretic peptide in conscious sheep and effect of hemorrhage.
Cameron VA; Espiner EA; Nicholls MG; Skidmore DS
Endocrinology; 1988 Feb; 122(2):407-14. PubMed ID: 2827996
[TBL] [Abstract][Full Text] [Related]
24. Glomerular hemodynamics of the clipped kidney: effects of captopril and diltiazem.
Frei U; Schindler R; Matthies C; Koch KM
J Pharmacol Exp Ther; 1992 Dec; 263(3):938-42. PubMed ID: 1469650
[TBL] [Abstract][Full Text] [Related]
25. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
26. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
[TBL] [Abstract][Full Text] [Related]
27. Endogenous angiotensin II modulates the effect of atrial natriuretic peptide on extracellular fluid partition.
Valentin JP; Nafrialdi N; Ribstein J; Mimran A
Am J Physiol; 1993 Apr; 264(4 Pt 2):R676-80. PubMed ID: 8386485
[TBL] [Abstract][Full Text] [Related]
28. Differential renal responses to atrial natriuretic peptide in two-kidney, one clip goldblatt hypertensive rats.
Huang WC; Wu JN; Chao DH
J Cardiovasc Pharmacol; 1989 Jan; 13(1):7-15. PubMed ID: 2468938
[TBL] [Abstract][Full Text] [Related]
29. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives.
Wilkins MR; Lewis HM; West MJ; Kendall MJ; Lote CJ
J Hum Hypertens; 1987 Jun; 1(1):47-51. PubMed ID: 2977404
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
Pesonen A; Leppäluoto J; Ruskoaho H
J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
[TBL] [Abstract][Full Text] [Related]
31. Influence of captopril on the serotonin-induced vasopressor effect in tail artery isolated from two-kidney, one-clip renal hypertensive rats.
Morelowska-Spierzak D; Pawlak D; Buczko W
Pol J Pharmacol; 1995; 47(5):417-22. PubMed ID: 8868133
[TBL] [Abstract][Full Text] [Related]
32. Suppression of plasma endothelin-1 level by alpha-human atrial natriuretic peptide and angiotensin converting enzyme inhibition in normal men.
Uemasu J; Matsumoto H; Kitano M; Kawasaki H
Life Sci; 1993; 53(11):969-74. PubMed ID: 8366764
[TBL] [Abstract][Full Text] [Related]
33. Natriuretic peptides buffer renin-dependent hypertension.
Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
[TBL] [Abstract][Full Text] [Related]
34. Effect of asiatic acid on the Ang II-AT
Maneesai P; Bunbupha S; Kukongviriyapan U; Senggunprai L; Kukongviriyapan V; Prachaney P; Pakdeechote P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Oct; 390(10):1073-1083. PubMed ID: 28733880
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic effects of captopril in one-kidney, one clip hypertensive rabbits.
Kogure M; Ichikawa S; Sakamaki T; Matsuo H; Tajima Y; Fujita H; Murata K
Clin Exp Hypertens A; 1984; 6(5):1035-54. PubMed ID: 6375906
[TBL] [Abstract][Full Text] [Related]
36. Chronic vs. acute hemodynamic effects of atrial natriuretic factor in conscious rats.
Harrison-Bernard LM; Vari RC; Holleman WH; Trippodo NC; Barbee RW
Am J Physiol; 1991 Jan; 260(1 Pt 2):R247-54. PubMed ID: 1825157
[TBL] [Abstract][Full Text] [Related]
37. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
Abu-Amarah I; Balment RJ
Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
[TBL] [Abstract][Full Text] [Related]
38. Increased vascular collagen and noncollagenous protein synthesis contributes to sustain chronic phase of two-kidney, one-clip renovascular hypertension.
Nakada T; Iijima Y; Kubota Y; Watanabe M; Ishigooka M; Suzuki H
J Urol; 1996 Sep; 156(3):1180-5. PubMed ID: 8709342
[TBL] [Abstract][Full Text] [Related]
39. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
40. Changes of atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats.
Matsubara H; Yamamoto J; Hirata Y; Mori Y; Oikawa S; Inada M
Circ Res; 1990 Jan; 66(1):176-84. PubMed ID: 2136812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
